# OnCo record adiuvo (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/adiuvo/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "adiuvo", "NCT00777244" ;
  schema:name "ADIUVO"@en ;
  schema:alternateName "ADIUVO trial"@en ;
  schema:description "ADIUVO asked whether people whose low-grade adrenal cancer had been fully removed should take the toxic drug mitotane for two years to prevent recurrence; recurrence and survival were no different from watching and waiting, so observation with regular scans is the standard for this group."@en ;
  schema:url <https://onco.cc/trials/adiuvo/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00777244> ;
  onco:status "negative" ;
  onco:tag "soc-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/localised-adrenocortical-carcinoma/>, <https://onco.cc/cancers/adrenocortical/> ;
  onco:drugs <https://onco.cc/drugs/mitotane/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-adiuvo-adjuvant-mitotane-low-grade-acc-terzolo-lancet-diabetes-endocrinol-2023/> .